Nucleoside analogue hepatotoxicity in HIV-infected patients

被引：0
|
作者：
Hernandez, LV [1 ]
Vincents, DJ [1 ]
Jerrold, JJ [1 ]
Ian, G [1 ]
机构：
[1] Univ Wisconsin, SSMC, Milwaukee, WI 53201 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
684
引用
收藏
页码：331A / 331A
页数：1
相关论文
共 50 条
  • [1] OXACILLIN HEPATOTOXICITY IN HIV-INFECTED PATIENTS
    SALIBA, B
    HERBERT, PN
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (12) : 1048 - 1048
  • [2] Lipodystrophy and nucleoside analogue therapy in HIV-infected patients:: Important question, few valid answers
    Savès, M
    Chêne, G
    Suissa, S
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (01) : 96 - 97
  • [3] Effect of Antiretroviral class on hepatotoxicity in HIV-infected patients
    Ritchey, Mary E.
    Laurent, Samantha A. St.
    Russo, Mark W.
    Jonsson-Funk, Michele L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S209 - S209
  • [4] Incidence of liver toxicity in HIV-infected patients receiving isolated dual nucleoside analogue antitretroviral therapy
    Verucchi, G
    Calza, L
    Manfredi, R
    Chiodo, F
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (04) : 546 - 548
  • [5] Effect of antiretroviral class on hepatotoxicity in HIV-infected patients.
    Ritchey, M.
    St Laurent, S.
    Russo, M.
    Jonsson-Funk, M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) : S119 - S119
  • [6] Lactic acidosis related to nucleoside therapy in HIV-infected patients
    Falcó, V
    Crespo, M
    Ribera, E
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (08) : 1321 - 1329
  • [7] Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients
    Coté, HCF
    Brumme, ZL
    Craib, KJP
    Alexander, CS
    Wynhoven, B
    Ting, LL
    Wong, H
    Harris, M
    Harrigan, PR
    O'Shaughnessy, MV
    Montaner, JSG
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (11): : 811 - 820
  • [8] Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens
    Bigoloni, Alba
    Gianotti, Nicola
    Spagnuolo, Vincenzo
    Galli, Laura
    Nozza, Silvia
    Cossarini, Francesca
    Salpietro, Stefania
    Carini, Elisabetta
    Piatti, Piermarco
    Vinci, Concetta
    Lazzarin, Adriano
    Castagna, Antonella
    AIDS, 2012, 26 (14) : 1837 - 1840
  • [9] Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity
    Casado, Jose L.
    Banon, Sara
    Rodriguez, Miguel A.
    Santiuste, Carmen
    Perez-Elias, Maria J.
    Moreno, Ana
    Moreno, Santiago
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (02) : 630 - 632
  • [10] POSTPRANDIAL SERUM CHOLYGLYCINE AS A MARKER OF ANTITUBERCULOUS DRUG HEPATOTOXICITY IN HIV-INFECTED PATIENTS
    ALEGRE, J
    DESEVILLA, TF
    FALCO, V
    ARMADANS, L
    VAZQUEZ, JMM
    CHEST, 1993, 104 (04) : 1312 - 1313
12345